{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:30:10Z","timestamp":1793331010910,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ejca.2022.05.038","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T04:43:46Z","timestamp":1657255426000},"page":"287-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Hypertension in long-term childhood cancer survivors after treatment with potentially nephrotoxic therapy; DCCSS-LATER 2: Renal study"],"prefix":"10.1016","volume":"172","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6961-1684","authenticated-orcid":false,"given":"Esmee C.M.","family":"Kooijmans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena J.H.","family":"van der Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia M.F.","family":"Pluijm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorine","family":"Bresters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8870-6539","authenticated-orcid":false,"given":"Eline","family":"van Dulmen-den Broeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margriet","family":"van der Heiden-van der Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marry M.","family":"van den Heuvel-Eibrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7619-7845","authenticated-orcid":false,"given":"Leontien C.M.","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline J.","family":"Loonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marloes","family":"Louwerens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian J.C.","family":"Neggers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Pilon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Ronckers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim J.E.","family":"Tissing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrica C.H.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gertjan J.L.","family":"Kaspers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arend","family":"B\u00f6kenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margreet A.","family":"Veening","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejca.2022.05.038_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1470-2045(13)70548-5","article-title":"Childhood cancer survival in Europe 1999\u20132007: results of EUROCARE-5\u2014a population-based study","volume":"15","author":"Gatta","year":"2014","journal-title":"Lancet Oncol"},{"issue":"24","key":"10.1016\/j.ejca.2022.05.038_bib2","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1001\/jama.297.24.2705","article-title":"Medical assessment of adverse health outcomes in long-term survivors of childhood cancer","volume":"297","author":"Geenen","year":"2007","journal-title":"J Am Med Assoc"},{"issue":"6","key":"10.1016\/j.ejca.2022.05.038_bib3","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/pbc.21695","article-title":"Children's Oncology G. Renal late effects in patients treated for cancer in childhood: a report from the Children's Oncology Group","volume":"51","author":"Jones","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2022.05.038_bib4","article-title":"Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer","volume":"3","author":"Kooijmans","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejca.2022.05.038_bib5","article-title":"Late effects of chemotherapeutic agents on renal function in childhood cancer survivors: a review of the literature","author":"O'Sullivan","year":"2016","journal-title":"Ir J Med Sci"},{"issue":"3","key":"10.1016\/j.ejca.2022.05.038_bib6","first-page":"359","article-title":"Clinical aspects of radiation nephropathy","volume":"19","author":"Breitz","year":"2004","journal-title":"Cancer Biother Radiopharm"},{"issue":"3","key":"10.1016\/j.ejca.2022.05.038_bib7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0959-8049(95)00618-4","article-title":"Renal function after unilateral nephrectomy for Wilms' tumour: the influence of radiation therapy","volume":"32A","author":"de Graaf","year":"1996","journal-title":"Eur J Cancer"},{"issue":"32","key":"10.1016\/j.ejca.2022.05.038_bib8","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1200\/JCO.2008.17.5257","article-title":"Long-term evaluation of Ifosfamide-related nephrotoxicity in children","volume":"27","author":"Oberlin","year":"2009","journal-title":"J Clin Oncol: Official J Am Soc Clin Oncol"},{"issue":"18","key":"10.1016\/j.ejca.2022.05.038_bib9","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1016\/j.ejca.2009.06.032","article-title":"Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors","volume":"45","author":"Skinner","year":"2009","journal-title":"Eur J Cancer (Oxford, England: 1990)"},{"issue":"6","key":"10.1016\/j.ejca.2022.05.038_bib10","doi-asserted-by":"crossref","first-page":"922","DOI":"10.2215\/CJN.09980912","article-title":"Long-term nephrotoxicity in adult survivors of childhood cancer","volume":"8","author":"Dekkers","year":"2013","journal-title":"Clin J Am Soc Nephrol : CJASN"},{"issue":"20","key":"10.1016\/j.ejca.2022.05.038_bib11","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jama.1996.03530440051036","article-title":"Blood pressure as a cardiovascular risk factor: prevention and treatment","volume":"275","author":"Kannel","year":"1996","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ejca.2022.05.038_bib12","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1158\/1055-9965.EPI-17-0510","article-title":"Blood pressure status in adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort Study","volume":"26","author":"Gibson","year":"2017","journal-title":"Cancer Epidemiol Biomark Prev\u202f:\u00a0a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"key":"10.1016\/j.ejca.2022.05.038_bib13","first-page":"34","article-title":"Longitudinal assessment of cardiovascular risk factors (CVRF) in adult survivors of pediatric cancer: a report from the childhood cancer survivor study (CCSS). Conference Abstract","volume":"76","author":"Meacham","year":"2011","journal-title":"Hormone Res Paediatr"},{"issue":"9","key":"10.1016\/j.ejca.2022.05.038_bib14","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.2215\/CJN.09620911","article-title":"Renal dysfunction and elevated blood pressure in long-term childhood cancer survivors","volume":"7","author":"Knijnenburg","year":"2012","journal-title":"Clin J Am Soc Nephrol: CJASN"},{"key":"10.1016\/j.ejca.2022.05.038_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28271","article-title":"Long-term renal function after treatment for unilateral, nonsyndromic Wilms tumor. A report from the St. Jude Lifetime Cohort Study","author":"Green","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2022.05.038_bib16","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/pbc.22518","article-title":"Increased prevalence of risk factors for cardiovascular disease in long-term survivors of acute lymphoblastic leukemia and Wilms tumor treated with radiotherapy","volume":"55","author":"Geenen","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2022.05.038_bib17","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.bbmt.2009.11.018","article-title":"Hypertension in long-term survivors of pediatric hematopoietic cell transplantation","volume":"16","author":"Hoffmeister","year":"2010","journal-title":"Biol Blood Marrow Transplant : J Am Soc Blood and Marrow Transplant"},{"issue":"33","key":"10.1016\/j.ejca.2022.05.038_bib18","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ejca.2022.05.038_bib19","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/HJH.0b013e328350bb40","article-title":"Ambulatory blood pressure monitoring and development of cardiovascular events in high-risk patients included in the Spanish ABPM registry: the CARDIORISC Event study","volume":"30","author":"de la Sierra","year":"2012","journal-title":"J Hypertens. Apr"},{"issue":"1","key":"10.1016\/j.ejca.2022.05.038_bib20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/01.HYP.0000170138.56903.7a","article-title":"Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study","volume":"46","author":"Dolan","year":"2005","journal-title":"Hypertens (Dallas, Tex : 1979)"},{"issue":"12","key":"10.1016\/j.ejca.2022.05.038_bib21","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/archinternmed.2011.230","article-title":"Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease","volume":"171","author":"Minutolo","year":"2011","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.1016\/j.ejca.2022.05.038_bib22","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/jjco\/hyt105","article-title":"The late effects of anticancer therapy after childhood Wilm's tumor: the role of diastolic function and ambulatory blood pressure monitoring","volume":"43","author":"Elli","year":"2013","journal-title":"Jpn J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ejca.2022.05.038_bib23","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s00467-018-3976-5","article-title":"Long-term renal follow-up of children treated with cisplatin, carboplatin, or ifosfamide: a pilot study","volume":"33","author":"McMahon","year":"2018","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.ejca.2022.05.038_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08880018.2018.1425784","article-title":"Prevalence of hypertension determined by ambulatory blood pressure monitoring (ABPM) and body composition in long-term survivors of childhood cancer","volume":"35","author":"Guler","year":"2018","journal-title":"Pediatr Hematol Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2022.05.038_bib25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/MPH.0000000000001349","article-title":"Prevalence and risk factors for arterial hypertension development in childhood ALL survivors","volume":"41","author":"Ociepa","year":"2019","journal-title":"J pediatr hematol\/oncol"},{"key":"10.1016\/j.ejca.2022.05.038_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jpeds.2020.12.005","article-title":"Kidney outcomes and hypertension in survivors of Wilms tumor: a prospective cohort study","volume":"230","author":"Chu","year":"2021","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.ejca.2022.05.038_bib27","first-page":"1226","article-title":"Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-1991)","volume":"94","author":"Kamps","year":"1999","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ejca.2022.05.038_bib28","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/sj.leu.2402489","article-title":"BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991-1996)","volume":"16","author":"Kamps","year":"2002","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.ejca.2022.05.038_bib29","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/ije\/dyu229","article-title":"Cohort Profile: LifeLines, a three-generation cohort study and biobank","volume":"44","author":"Scholtens","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"9","key":"10.1016\/j.ejca.2022.05.038_bib30","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/HJH.0b013e328363e964","article-title":"European Society of Hypertension position paper on ambulatory blood pressure monitoring","volume":"31","author":"O'Brien","year":"2013","journal-title":"J Hypertens"},{"issue":"1","key":"10.1016\/j.ejca.2022.05.038_bib31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ejca.2022.05.038_bib32","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1515\/CCLM.2010.318","article-title":"First certified reference material for cystatin C in human serum ERM-DA471\/IFCC","volume":"48","author":"Grubb","year":"2010","journal-title":"Clinical Chem Lab Med"},{"key":"10.1016\/j.ejca.2022.05.038_bib33","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ejca.2022.05.038_bib34","series-title":"Nederland de maat genomen, 2009-2010. Monitoring van risicofactoren in de algemene bevolking. RIVM-rapport nr. 260152001\/2011","author":"Blokstra","year":"2011"},{"issue":"13","key":"10.1016\/j.ejca.2022.05.038_bib35","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1200\/JCO.18.01764","article-title":"Therapy-related cardiac risk in childhood cancer survivors: an analysis of the Childhood Cancer Survivor Study","volume":"37","author":"Bates","year":"2019","journal-title":"J Clin Oncol: Official J Am Soc Clin Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2022.05.038_bib36","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jama.2013.184182","article-title":"Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries","volume":"310","author":"Chow","year":"2013","journal-title":"Jama"},{"issue":"29","key":"10.1016\/j.ejca.2022.05.038_bib37","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1200\/JCO.2013.49.3205","article-title":"Modifiable risk factors and major cardiac events among adult survivors of childhood cancer","volume":"31","author":"Armstrong","year":"2013","journal-title":"J Clin Oncol: Official J Am Soc Clin Oncol"},{"issue":"32","key":"10.1016\/j.ejca.2022.05.038_bib38","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1681\/ASN.2020060849","article-title":"Kidney function after treatment for childhood cancer: a report from the St. Jude Lifetime Cohort Study","volume":"2","author":"Green","year":"2021","journal-title":"J Am Soc Nephrol : JASN"},{"key":"10.1016\/j.ejca.2022.05.038_bib39","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejca.2021.06.050","article-title":"Late-onset kidney failure in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study","volume":"155","author":"Dieffenbach","year":"2021","journal-title":"Eur J Cancer (Oxford, England: 1990)"},{"issue":"4","key":"10.1016\/j.ejca.2022.05.038_bib40","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ejca.2010.01.002","article-title":"Hypertension in long-term survivors of childhood cancer: a nested case-control study","volume":"46","author":"Cardous-Ubbink","year":"2010","journal-title":"Eur J Cancer (Oxford, England: 1990)"},{"issue":"1","key":"10.1016\/j.ejca.2022.05.038_bib41","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.hlc.2019.08.006","article-title":"Masked hypertension: a systematic review","volume":"29","author":"Thakkar","year":"2020","journal-title":"Heart, Lung Circulation"},{"issue":"6","key":"10.1016\/j.ejca.2022.05.038_bib42","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/HYPERTENSIONAHA.115.06896","article-title":"Hypertension in chronic kidney disease part 2: role of ambulatory and home blood pressure monitoring for assessing alterations in blood pressure variability and blood pressure profiles","volume":"67","author":"Parati","year":"2016","journal-title":"Hypertension (Dallas, Tex: 1979)"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922003264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922003264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:38:29Z","timestamp":1760733509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804922003264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":42,"alternative-id":["S0959804922003264"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2022.05.038","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypertension in long-term childhood cancer survivors after treatment with potentially nephrotoxic therapy; DCCSS-LATER 2: Renal study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2022.05.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}